UNLABELLED: Several controlled clinical trials have studied the efficacy of topiramate in the treatment of alcoholism. In this paper, we have performed a meta-analysis of those trials in which topiramate was compared with placebo and then we reviewed its efficacy in trials in which it was compared with other drugs. METHOD: A quantitative synthesis of data was per-formed using inverse variance weighting in a random effects model. RESULTS: Based on three placebo-controlled trials, topiramate is more efficacious than placebo in reducing the percentage of heavy drinking days (23.2%, 95% confidence interval [CI]: 15.7 to 34.4), increasing the number of days of abstinence (mean difference: 2.9 days, 95% CI: 2.5 to 3.3),and lowering the logarithm of g-GT levels (mean difference:0.075 95% CI: 0.048 to 0.118). Two trials suggested that topiramate is also more efficacious than naltrexone, and one open-label study reported better results for disulfiram than for topiramate. CONCLUSION: Topiramate can be used in alcohol dependence. Adverse effects such as paresthesia or insomnia should be taken into account when prescribing topiramate.Its optimal dosage requires further research.
UNLABELLED: Several controlled clinical trials have studied the efficacy of topiramate in the treatment of alcoholism. In this paper, we have performed a meta-analysis of those trials in which topiramate was compared with placebo and then we reviewed its efficacy in trials in which it was compared with other drugs. METHOD: A quantitative synthesis of data was per-formed using inverse variance weighting in a random effects model. RESULTS: Based on three placebo-controlled trials, topiramate is more efficacious than placebo in reducing the percentage of heavy drinking days (23.2%, 95% confidence interval [CI]: 15.7 to 34.4), increasing the number of days of abstinence (mean difference: 2.9 days, 95% CI: 2.5 to 3.3),and lowering the logarithm of g-GT levels (mean difference:0.075 95% CI: 0.048 to 0.118). Two trials suggested that topiramate is also more efficacious than naltrexone, and one open-label study reported better results for disulfiram than for topiramate. CONCLUSION:Topiramate can be used in alcohol dependence. Adverse effects such as paresthesia or insomnia should be taken into account when prescribing topiramate.Its optimal dosage requires further research.
Authors: Andrea K Finlay; Ingrid Binswanger; Christine Timko; Joel Rosenthal; Sean Clark; Jessica Blue-Howells; Jim McGuire; Hildi Hagedorn; Jessie Wong; James Van Campen; Alex H S Harris Journal: Crim Justice Policy Rev Date: 2016-04-18
Authors: Andrea K Finlay; Laura S Ellerbe; Jessie J Wong; Christine Timko; Anna D Rubinsky; Shalini Gupta; Thomas R Bowe; Jennifer L Burden; Alex H S Harris Journal: J Subst Abuse Treat Date: 2017-03-10